Medicare limits payments for new Alzheimer’s drug to clinical trials

  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 72%

United States Headlines News

United States Latest News,United States Headlines

The federal government affirmed its plan to limit coverage for a costly new medication for Alzheimer’s disease, restricting it to Medicare patients enrolled in clinical trials.

Those trials could be approved by the FDA itself or by the National Institutes of Health, and would not have to be sanctionedIn a small victory for Alzheimer’s patients, CMS said if the FDA approves future drugs through a more traditional process, it would allow wider access to coverage for those medications. Those drugs also would target the amyloid plaques suspected of causing the devastating impacts of Alzheimer’s.

But some major health systems have refused to offer the medication, developed by the drugmaker Biogen, because some experts doubt its efficacy. The watchdog group Public Citizen — which frequently criticizes the FDA — called for

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Please help me! My name is Lin donglong, an employee of China telecom fuzhou branch. Company manager huang fei (communist party of China) organized the leadership of the gang of evil forces brutal persecution: surveillance location, insult,abuse, framed to take nude photos of me

Here is the same video taken from a different angle.. How many Police Personals can you see in this video while the Mahant is giving Rape threats to Muslim Women? ArrestBajrangMuni

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 95. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New generation of cancer-preventing vaccines could wipe out tumors before they formCancer-preventing vaccines are now being tested in healthy people at high risk for disease—and early trials are yielding glimmers of promise. LongReads Fantastic Really interesting article. ScienceMagazine DO NOT TRUST ANY VACCINE
Source: NewsfromScience - 🏆 515. / 51 Read more »

San Diego will be part of national clinical trial on COVID-19 vaccinesEffort will be led locally by UC San Diego with almost half of participants 65 or older
Source: sdut - 🏆 5. / 95 Read more »

UCSD joins clinical trial to evaluate need for additional COVID-19 boostersUC San Diego joined a Phase II clinical trial to evaluate additional COVID-19 booster shots to see if different vaccine regimens can broaden immune responses in adults, it was announced Wednesday.
Source: 10News - 🏆 732. / 50 Read more »

UCSD joins clinical trial to evaluate need for additional COVID-19 boostersUC San Diego joined a Phase II clinical trial to evaluate additional COVID-19 booster shots to see if different vaccine regimens can broaden immune responses in adults, it was announced Wednesday.
Source: KPBSnews - 🏆 240. / 63 Read more »

Pfizer to Buy Respiratory-Virus DrugmakerThe New York drugmaker said it agreed to acquire the clinical-stage biopharmaceutical company that is targeting respiratory syncytial virus, which can lead to severe lower-respiratory-tract infections.
Source: WSJhealth - 🏆 413. / 53 Read more »